drugset
drugset / Trial / NCT06772818

A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-017)

NCT06772818 ↗

Phase 1 Completed 20 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of the study is to learn what happens to levels of nemtabrutinib in a healthy person's body over time. Researchers will compare what happens to nemtabrutinib in the body when it is given under fasted (on an empty stomach) and fed (after a high-fat meal) conditions.

Timeline

Start
2023-10-02
Primary completion
2023-12-20
Completion
2024-02-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Nemtabrutinib Other / unclassified — Oral

Indications

No indication recorded.